A.L.S. Drug Relyvrio Will Be Taken Off the Market, Its Maker Says April 04, 2024 Amyotrophic Lateral Sclerosis Brain Clinical Trials Corporations Drugs (Pharmaceuticals) NYT NYTimes Suits and Litigation (Civil) your-feed-healthcare your-feed-science +